Home  >  TopNews
Eppen_Research3neo_Feb26
you can get e-magazine links on WhatsApp. Click here
TopNews
  Indian pharma cos applaud US FDA's strong stance on safety reporting in BA/BE studies,   December 22, 2025
  India to seek collaborative potential with Bangladesh pharma market at Asia Pharma Expo 2025,   December 23, 2024
  US FDA norms on container closure systems to enhance quality and reliability of drug’s shelf-life,   August 12, 2024
  Pharma & medical devices industry underscore efforts to tackle misinformation on labels as US FDA issues related norms,   July 26, 2024
  Indian diabetologists view US FDA’s recent guidance on diabetic foot infections timely,   June 29, 2024
  US FDA guidance on formulation development to bolster opportunities for Indian companies,   June 04, 2024
  Clinical trial companies see immense relevance on US FDA Electronic Submission Safety Reports,   April 26, 2024
  Indian medical device industry views US FDA Premarket Cybersecurity norms to boost customer confidence,   April 08, 2024
  Pharma companies view gene therapy as viable option as US FDA issues human gene therapy products guidance,   April 01, 2024
  Pharma industry views US FDA guidance on developing drugs for early Alzheimer’s disease as invaluable,   March 26, 2024
  US FDA’s draft on AMT Designation Programme to propel Industry 4.0,   March 13, 2024
  Indian pharma sees US FDA’s remote regulatory assessment to reduce delays in approvals,   February 12, 2024
  US FDA issues draft guidance on drugs for diabetic foot infections as India & and the world battle its complications,   November 20, 2023
  US House Committee asks US FDA to submit details on inspection of facilities in India and China,   July 21, 2023
  Indian pharma sees benefits of US FDA norms on psychedelic drugs going by its potential to treat mental conditions,   July 05, 2023
  Indian pharma sees the draft ICH norms for good clinical practices to boost better human studies outcome,   June 26, 2023
  Industry keen on scientific considerations in paediatric drug development,   May 30, 2023
  Indian pharma views new Ultimate Guide to CFR Part 11 as a ready reckoner to quick compliance,   April 22, 2023
  GDUFA helps reduce backlog of pending applications: pharma cos,   April 18, 2023
  Indian healthcare centres see relevance to US FDA Orthopaedic Non-Spinal Bone Plates, Screws and Washers guidance,   April 12, 2023

  • Results Found: 231
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 12
 Back
 
CP_CPHI_Korea2026
ChemExpo_India_2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram